SLC5A2 and diabetes mellitus: In particular, for DM patients with increased NAP, the selection of GLP-1 receptor agonists or SGLT-2 inhibitors as an antidiabetic drug would be recommended, because their direct reno-protective mechanisms, such as the suppression of inflammation and inhibition of oxidative injury [84,85,86], may also be effective for tubular injury.